ES2145003T3 - Composicion que contiene un derivado de dioxabiciclo(3.3.0)octano. - Google Patents

Composicion que contiene un derivado de dioxabiciclo(3.3.0)octano.

Info

Publication number
ES2145003T3
ES2145003T3 ES92305491T ES92305491T ES2145003T3 ES 2145003 T3 ES2145003 T3 ES 2145003T3 ES 92305491 T ES92305491 T ES 92305491T ES 92305491 T ES92305491 T ES 92305491T ES 2145003 T3 ES2145003 T3 ES 2145003T3
Authority
ES
Spain
Prior art keywords
dioxabiciclo
octano
derivative
composition containing
food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92305491T
Other languages
English (en)
Inventor
Ayako Nakabayashi
Yoshinori Kitagawa
Kengo Akimoto
Michihiro Sugano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15345304&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2145003(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ES2145003T3 publication Critical patent/ES2145003T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03Organic compounds
    • A23L29/035Organic compounds containing oxygen as heteroatom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

UNA COMPOSICION COSMETICA, FARMACEUTICA, PARA BEBER Y ALIMENTICIA DE UN ADITIVO ALIMENTARIO QUE CONTIENE UN DERIVADO DE DIOXABICICLO[3.3.O]OCTANO REPRESENTADO POR LA SIGUIENTE FORMULA GENERAL (I): EN DONDE R1, R2, R3, R4, R5 Y R6 REPRESENTAN INDEPENDIENTEMENTE UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO QUE TIENE DE 1 A 3 ATOMOS DE CARBONO, O R1 Y R2 Y/O R4 Y R5 JUNTOS FORMAN UN GRUPO METILENO O UN GRUPO ETILENO, Y N, M Y LANDA SON 0 O 1; Y UN ANTIOXIDANTE.
ES92305491T 1991-06-15 1992-06-15 Composicion que contiene un derivado de dioxabiciclo(3.3.0)octano. Expired - Lifetime ES2145003T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14371591A JP3283274B2 (ja) 1991-06-15 1991-06-15 新規組成物

Publications (1)

Publication Number Publication Date
ES2145003T3 true ES2145003T3 (es) 2000-07-01

Family

ID=15345304

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92305491T Expired - Lifetime ES2145003T3 (es) 1991-06-15 1992-06-15 Composicion que contiene un derivado de dioxabiciclo(3.3.0)octano.

Country Status (10)

Country Link
US (1) US5637610A (es)
EP (1) EP0519673B1 (es)
JP (1) JP3283274B2 (es)
AT (1) ATE192038T1 (es)
CA (1) CA2071248C (es)
DE (1) DE69230958T2 (es)
DK (1) DK0519673T3 (es)
ES (1) ES2145003T3 (es)
PT (1) PT519673E (es)
SG (1) SG47437A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022971A1 (en) * 1994-02-25 1995-08-31 New England Deaconess Hospital Corporation Anti-inflammatory and infection protective effects of sesamin-based lignans
JP3818680B2 (ja) * 1994-05-12 2006-09-06 サントリー株式会社 アレルギー症状の予防又は改善剤
JPH08268887A (ja) * 1995-02-01 1996-10-15 Suntory Ltd 高血圧症又はそれに起因する医学的症状の予防又は改善剤
KR970705345A (ko) * 1995-07-04 1997-10-09 도리이 신이치로 오메가 6계ㆍ오메가 3계 불포화 지방산의 밸런스 조절제를 배합하여 이루어진 식품 조성물(Food composition containing balancing agent for ω- 6 and ω- 3 unsaturated fatty acids)
JPH11246427A (ja) * 1998-03-04 1999-09-14 Kadoya Sesami Mills Inc 糖・脂質代謝活性化剤
US7005446B1 (en) * 1999-04-20 2006-02-28 Alcon Manufacturing, Ltd. Use of AP-1 activators to treat glaucoma and ocular hypertension
JP4388248B2 (ja) * 2001-10-29 2009-12-24 株式会社日立製作所 最適ポートフォリオ決定方法および装置
KR100457732B1 (ko) * 2002-07-20 2004-11-17 주식회사 렉스진바이오텍 광학합성의 비대칭 푸로푸란리그난 화합물의 신규 제조방법
US20080275110A1 (en) * 2004-12-28 2008-11-06 Yoshiko Ono Sesamin/Episesamin Compositions
US20060182828A1 (en) * 2005-02-17 2006-08-17 Colman John S Methods of reducing lipid peroxidation and achieving related health benefits by the administration of tocopherol and sesame lignans
KR101327649B1 (ko) 2005-03-31 2013-11-12 산토리 홀딩스 가부시키가이샤 리그난류 화합물 함유 수중 유적형 에멀션 및 그것을함유하는 조성물
AU2007237685B2 (en) * 2006-03-15 2012-08-09 Suntory Holdings Limited Compositions containing riboflavin and sesamin-class compounds
US9408803B2 (en) 2006-03-31 2016-08-09 Suntory Holdings Limited Compositions containing lignan-class compounds
WO2008044550A1 (fr) 2006-10-04 2008-04-17 Suntory Limited Émulsion de type huile/eau/huile contenant un composé de lignane, et composition la contenant
KR101525264B1 (ko) * 2007-03-15 2015-06-02 산토리 홀딩스 가부시키가이샤 항피로제
WO2009038089A1 (ja) * 2007-09-19 2009-03-26 Suntory Holdings Limited セサミン類及びビタミンeを含有する抗疲労剤
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
JP5348805B2 (ja) * 2011-08-18 2013-11-20 かどや製油株式会社 水分散性セサミン類粉末の製造方法
KR20130046115A (ko) * 2011-10-27 2013-05-07 (주)아모레퍼시픽 시링가레시놀을 포함하는 혈관 노화 억제용 조성물
JP7366991B2 (ja) * 2019-02-28 2023-10-23 株式会社えがお 体重増加抑制・低減用組成物
WO2021006822A1 (en) * 2019-07-08 2021-01-14 Chiangmai University Pharmaceutical compositions having synergistic effects of natural extracts for cancer treatment undergoing chemotherapy

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA828513B (en) * 1981-11-24 1983-12-28 Shelleden Products Ltd Pharmaceutical preparations and compositions
US4427694A (en) * 1982-06-11 1984-01-24 The Vinoxen Company, Inc. Sesamin as a psychotropic agent
JPS6041611A (ja) * 1983-08-17 1985-03-05 Sankyo Co Ltd 血中脂質低下剤
JPS6043365A (ja) * 1983-08-19 1985-03-07 M S C:Kk 新規な食品
JPS60197621A (ja) * 1984-03-19 1985-10-07 Hohnen Oil Co Ltd コレステロ−ル低下剤
JPS60224629A (ja) * 1984-04-23 1985-11-09 Kao Corp 生体内過酸化脂質生成抑制剤組成物
JPS61212518A (ja) * 1985-03-19 1986-09-20 Nippon Paint Co Ltd 血液凝固促進剤
JPS62581A (ja) * 1985-06-26 1987-01-06 Takemoto Oil & Fat Co Ltd フエノ−ル性天然抗酸化性物質の製造方法
JPS6243365A (ja) * 1985-08-20 1987-02-25 Honda Motor Co Ltd トラクタの前後輪操舵装置
JPS6244145A (ja) * 1985-08-22 1987-02-26 Horiuchi:Kk 抗肥満食品
JPH0651632B2 (ja) * 1985-09-05 1994-07-06 昭和産業株式会社 降コレステロ−ル剤
JPH0787763B2 (ja) * 1986-08-07 1995-09-27 日清製油株式会社 食品用品質保持剤
JPH01202278A (ja) * 1988-02-05 1989-08-15 Nisshin Oil Mills Ltd:The 食品用品質保持剤
JPH02138120A (ja) * 1988-11-21 1990-05-28 Nippon Kayaku Co Ltd リポキシゲナーゼ阻害剤
JP3070611B2 (ja) * 1989-03-07 2000-07-31 サントリー株式会社 △▲上5▼―不飽和化酵素阻害剤
ES2235205T3 (es) * 1989-07-21 2005-07-01 Suntory Limited Capsula que contiene compuestos de dioxabiciclo (3.3.0)octano.
JP3001589B2 (ja) * 1989-07-21 2000-01-24 サントリー株式会社 リグナン類含有飲食物
JP3183664B2 (ja) * 1990-10-22 2001-07-09 サントリー株式会社 コレステロール及び胆汁酸の代謝阻害剤
JPH04290822A (ja) * 1991-03-15 1992-10-15 Nippon Oil & Fats Co Ltd アレルギー予防薬および食品

Also Published As

Publication number Publication date
PT519673E (pt) 2000-09-29
DE69230958T2 (de) 2000-10-05
JPH04368326A (ja) 1992-12-21
EP0519673A1 (en) 1992-12-23
DE69230958D1 (de) 2000-05-31
JP3283274B2 (ja) 2002-05-20
DK0519673T3 (da) 2000-08-07
CA2071248A1 (en) 1992-12-16
ATE192038T1 (de) 2000-05-15
EP0519673B1 (en) 2000-04-26
SG47437A1 (en) 1998-04-17
CA2071248C (en) 2005-07-19
US5637610A (en) 1997-06-10

Similar Documents

Publication Publication Date Title
ES2145003T3 (es) Composicion que contiene un derivado de dioxabiciclo(3.3.0)octano.
HK1011689A1 (en) Bis(3,4-dialkylbenzylidene) sorbitol acetals and compositions containing same
AU716372C (en) Food composition containing an omega-6/omega-3 unsaturated fatty acid balance modifier
ATE57695T1 (de) 2-2-dimethyl-3-hydroxy-3-propargyl-4-(1,2,4triazol-1-yl)-butanderivate mit pflanzenwachstumsregulierender wirkung.
CA2053820A1 (en) Method of Inhibiting Metabolism of Cholesterol
CA2035038A1 (en) Synthetic intermediates of 2-alkynyladenosines, processes for preparing the synthetic intermediates, processes for preparing 2-alkynyladenosines utilizing the synthetic intermediates, and stable 2-alkynyladenosine derivatives
DE3165000D1 (en) 5-acylsalicylanilides derivatives and method for inhibiting the growth of microorganisms
IL90724A0 (en) Novel esters and pharmaceutical compositions containing same
NZ230128A (en) Dibenzooxepine-pyridinium and -pyrrolo derivatives and pharmaceutical compositions
SE8600046L (sv) Anvendning av en esterforening som temporer baktericid och produkt innehallande esterforeningen
GB9119615D0 (en) Compound,preparation and use
SI0681788T1 (en) Dioxabicyclo(3.3.0) octane derivatives, e.g. sesamin etc., for prevention or alleviation of allergy symptoms
AU637217B2 (en) Wood preservative compositions
AU4726089A (en) Benzoxazepine derivative
AU2474488A (en) Photochromatic composition and photochromatic articles which contain it
ES2044883T3 (es) Procedimiento para preparar quinoxalinas sustituidas.
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
GB1530118A (en) Acylcyclohexenes and their use in perfumery compositions
ES8606319A1 (es) Un metodo para producir un derivado de acido ascorbico

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 519673

Country of ref document: ES